Skip to content

Rachel E. Fargason

2 papers in the library · 16 citations · publishing 2023-2025

Papers

Delta-8-THC association with psychosis: A case report with literature review

Frontiers in Psychiatry February 20, 2023 Chelsea R. Miller, Bradley G. Burk, Rachel E. Fargason et al. 16 citations

Three patients who regularly used only delta-8-tetrahydrocannabinol (Δ8-THC), a federally unregulated cannabis derivative, developed psychotic and paranoid symptoms severe enough to require admission to a university psychiatric hospital. The symptoms exceeded the severity of their previous psychiatric episodes and included new-onset violence and visual hallucinations in two patients, including one with no prior psychiatric history and one on a therapeutic antipsychotic dose. A third patient developed bizarre, fixed delusions of puppies dissolving in the bathtub. The report documents a temporal association between Δ8-THC use and psychosis, though conclusions are limited by reliance on self-reported use and possible confounding factors.

Dextromethorphan in Cough Syrup: The Poor Man's Psychosis.

Psychopharmacology bulletin August 12, 2025 Bridgette Martinak, Ramy A Bolis, J. Black et al.

Dextromethorphan (DXM), a common over-the-counter cough suppressant, can cause psychosis when abused at high doses (over 1500 mg/day), producing delusions, hallucinations, and paranoia similar to phencyclidine (PCP). A case of severe DXM use disorder with psychotic disorder in a 40-year-old woman resolved only after treatment with an antipsychotic and mood stabilizer. DXM is not detected on standard urine drug screens, and its abuse may be an under-recognized cause of substance-induced psychosis. Clinicians should be aware of these psychiatric risks.